000 04289cam a2200445 i 4500
001 on1286956202
003 OCoLC
005 20240726104517.0
008 211202s2022 sz a ob 000 0 eng d
020 _a3030867056
020 _a9783030867058
029 1 _aAU@
_b000070299271
029 1 _aAU@
_b000070419128
040 _aYDX
_beng
_erda
_epn
_cYDX
_dGW5XE
_dEBLCP
_dOCLCF
_dOCLCO
_dDKU
_dNT
_dOCLCQ
_dOCLCO
049 _aSBIM
050 0 4 _aRA644
_b.F438 2022
100 1 _aCascella, Marco,
_e1
245 1 0 _aFeatures and management of acute and chronic neuro-Covid /Marco Cascella, Elvio De Blasio.
260 _aCham :
_bSpringer,
_c(c)2022.
300 _a158 pages :
_billustrations, charts :
_c24 cm
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _adata file
_2rda
504 _a1
505 0 0 _aPart I. Pathophysiology of COVID-19-associated neurotoxicity
505 0 0 _aAn update on preclinical findings --
_tOngoing clinical investigations --
_tPerspectives
505 0 0 _aPart II. Clinical manifestations of acute neurotoxicity
505 0 0 _aClinical features --
_tCNS complications --
_tPNS complications --
_tDiagnosis.-Management --
_tPerspectives
505 0 0 _aPart III. Neurological and psychiatric sequelae in COVID-19 survivors: Clinical features
505 0 0 _aNeurological late complications --
_tpsychological and psychiatric sequelae.-Diagnosis --
_tTools --
_tThe role of imaging --
_tPreventive strategies --
_tSocial and economic impact.-Multidisciplinary management --
_tPerspectives
520 0 _aThis book underlines how COVID-19 is a multisystem inflammatory disease and how its pathophysiology can predispose to an increased risk of neurological issues. Several scientific pieces of evidence showes the mechanisms underlying the neuroinvasive capacity of the SARS-CoV-2 through direct viral damage and indirect processes entering the CNS by different routes including the vasculature, the olfactory and trigeminal nerves, the cerebrospinal fluid, and the lymphatic system inducing a direct neurotoxicity. Furthermore, the pro-inflammatory cytokine storm and oxidative stress can induce microglial activation and damage to the blood-brain barrier, culminating in widespread neuroinflammatory process. This acute neurotoxicity is clinically expressed as anosmia and ageusia, headache, nausea and vomiting, but other neurologic manifestations such as acute cerebrovascular diseases, consciousness impairment due to encephalitis, and meningitis are also described. The PNS can also be affected by infectious damage and clinical manifestations including Guillain-Barr e syndrome, polyneuritis cranialis, and Miller Fisher Syndrome. A special issue concerns the neurocognitive dysfunction and altered consciousness manifested as delirium, agitation and confusion. Non-specific symptoms such as dizziness, seizures can accompany clinical pictures. Regardless of the admission diagnosis, a high percentage of patients discharged from ICUs develop disabilities affecting physical, cognitive and psychological activities. The symptoms such as asthenia, memory disturbances, depression, sleep disturbances, anxiety, and Post-traumatic stress disorder (PTSD), configure the so-called Post-intensive Care Syndrome (PICS). Multimodal management during the ICU stay and implementation of follow-up programs at patient discharge can reduce the incidence of this syndrome, improving the quality of life of surviving patients. In this complex scenario, a careful clinical approach through reliable diagnostic tools, and epidemiological studies aimed at evaluating the dimensions of the problem also in economic terms, is urgently needed. This book represents a valuable aid for all those healthcare professionals (intensivists, neurologist and psychiatrists, as well) involved in the management of these critically ill patients.
530 _a2
_ub
650 0 _aCOVID-19 (Disease)
_xPathophysiology.
650 0 _aNeurologic manifestations of general diseases.
650 0 _aNeurologic Manifestations.
655 4 _aMEDICAL.
700 1 _aDe Blasio, Elvio,
_e1
942 _cNUR
_eAMAZON
_hRA
_i2021-2022
_k129.59
_m2022
_nNURS
_O112-6793931-0707467
_RNURSING DEPARTMENT
_2lcc
999 _c69159
_d69159
902 _a1
_bCynthia Snell
_c1
_dCynthia Snell